Global Cancer Drug Sales Revenue Projected to Reach US$ 282.9 Billion by 2025
- A Small Font
- A Medium Font
- A Bigger Font
Global revenue from cancer drug sales reached US$143.9 billion in 2019. According to the Statista Health Market Outlook, this figure is projected to increase to US$196.7 billion in 2022 and reach US$282.9 billion in 2025.
Meanwhile, the market share of cancer drugs in the pharmaceutical sector was 15.7% in 2019. This is projected to reach 18% in 2022 and increase further to almost 22% in 2025.
Statista also reports that cancer drugs constitute the largest segment of the global pharmaceutical market. The second largest segment is vaccines, which saw sales increase by over 142% in 2021 due to the COVID-19 pandemic.
Following cancer drugs and vaccines, diabetes medications, anti-rheumatic drugs, and immunosuppressants (drugs to suppress the immune system) are the next largest segments in the pharmaceutical field.
Globally, the pharmaceutical market shows steady growth, driven by innovation and increasing demand for healthcare services, particularly in developing countries.
"Disclosure: This is an AI-generated translation of the original article. We strive for accuracy, but please note that automated translations may contain errors or slight inconsistencies."
Related Data
Latest Data Stories
Trending Topics
Popular Data